CR8178A - Sistemas de emulsion que contienen derivados de azetidina - Google Patents

Sistemas de emulsion que contienen derivados de azetidina

Info

Publication number
CR8178A
CR8178A CR8178A CR8178A CR8178A CR 8178 A CR8178 A CR 8178A CR 8178 A CR8178 A CR 8178A CR 8178 A CR8178 A CR 8178A CR 8178 A CR8178 A CR 8178A
Authority
CR
Costa Rica
Prior art keywords
azetidine
systems containing
containing derivatives
emulsion systems
refers
Prior art date
Application number
CR8178A
Other languages
English (en)
Inventor
Cote Sophie
Peracchia Maria-Teresa
Bobineau Valerie
Original Assignee
Aventis Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma filed Critical Aventis Pharma
Publication of CR8178A publication Critical patent/CR8178A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se refiere a sistemas emulsionantes que contienen derivados de azetidina. Se refiere a nuevas formulaciones de derivados de azetidina para administracion oral.
CR8178A 2003-07-18 2006-01-06 Sistemas de emulsion que contienen derivados de azetidina CR8178A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291797A EP1498123A1 (en) 2003-07-18 2003-07-18 Emulsifying systems containing azetidine derivatives

Publications (1)

Publication Number Publication Date
CR8178A true CR8178A (es) 2007-12-04

Family

ID=33462260

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8178A CR8178A (es) 2003-07-18 2006-01-06 Sistemas de emulsion que contienen derivados de azetidina

Country Status (31)

Country Link
US (1) US20050037062A1 (es)
EP (2) EP1498123A1 (es)
JP (1) JP2009513559A (es)
KR (1) KR20060040690A (es)
CN (1) CN1822830A (es)
AR (1) AR045912A1 (es)
AU (1) AU2004262497A1 (es)
BR (1) BRPI0412239A (es)
CA (1) CA2532668A1 (es)
CR (1) CR8178A (es)
EC (1) ECSP066291A (es)
GT (1) GT200400134A (es)
HR (1) HRP20060021A2 (es)
IL (1) IL173113A0 (es)
MA (1) MA27921A1 (es)
MX (1) MXPA06000478A (es)
MY (1) MY142076A (es)
NO (1) NO20060510L (es)
NZ (1) NZ544707A (es)
OA (1) OA13190A (es)
PA (1) PA8606601A1 (es)
PE (1) PE20050699A1 (es)
RS (1) RS20050971A (es)
RU (1) RU2348615C2 (es)
SG (1) SG144140A1 (es)
TN (1) TNSN06012A1 (es)
TW (1) TW200522946A (es)
UA (1) UA82539C2 (es)
UY (1) UY28422A1 (es)
WO (1) WO2005013972A1 (es)
ZA (1) ZA200600489B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498122A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid systems containing azetidine derivatives
CA2626579A1 (en) * 2005-10-25 2007-05-03 Abbott Laboratories Formulation comprising a drug of low water solubility and method of use thereof
JP2010510814A (ja) * 2006-09-29 2010-04-08 プルーロームド インコーポレイテッド 砕石術の間の結石および断片の後方移動の防止方法
MX2010001730A (es) * 2007-08-21 2010-03-10 Basilea Pharmaceutica Ag Composicion antimicotica.
FR2923719B1 (fr) * 2007-11-15 2009-11-20 Sanofi Aventis Compositions pharmaceutiques a base de derives d'azetidine
IT1394400B1 (it) * 2009-02-25 2012-06-15 Neuroscienze Pharmaness S C Ar L Composizioni farmaceutiche
WO2016164770A1 (en) * 2015-04-10 2016-10-13 Bioresponse, L.L.C. Self-emulsifying formulations of dim-related indoles
CN111759823B (zh) * 2015-09-17 2022-12-30 阿赖耶识（上海）生物技术有限公司 一种高稳定的非囊泡型纳米颗粒及其在治疗微生物感染中的应用
AU2018263868A1 (en) 2017-05-02 2019-12-12 Merck Sharp & Dohme Llc Formulations of anti-LAG3 antibodies and co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
US20240277615A1 (en) * 2021-06-11 2024-08-22 Universidade Da Beira Interior Self-emulsifying composition, production methods and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
GB9600235D0 (en) * 1996-01-05 1996-03-06 Pfizer Ltd Therapeutic agents
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
FR2829027A1 (fr) * 2001-08-29 2003-03-07 Aventis Pharma Sa Association avec un antagoniste du recepteur cb1, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de parkinson
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine

Also Published As

Publication number Publication date
MA27921A1 (fr) 2006-06-01
RU2006105000A (ru) 2006-07-10
CN1822830A (zh) 2006-08-23
SG144140A1 (en) 2008-07-29
WO2005013972A1 (en) 2005-02-17
ZA200600489B (en) 2007-04-25
CA2532668A1 (en) 2005-02-17
AR045912A1 (es) 2005-11-16
PA8606601A1 (es) 2005-03-03
MXPA06000478A (es) 2006-04-05
ECSP066291A (es) 2006-07-28
AU2004262497A2 (en) 2005-02-17
PE20050699A1 (es) 2005-09-15
JP2009513559A (ja) 2009-04-02
KR20060040690A (ko) 2006-05-10
UY28422A1 (es) 2005-02-28
RU2348615C2 (ru) 2009-03-10
AU2004262497A1 (en) 2005-02-17
NZ544707A (en) 2009-01-31
EP1498123A1 (en) 2005-01-19
NO20060510L (no) 2006-01-31
RS20050971A (sr) 2008-06-05
IL173113A0 (en) 2006-06-11
MY142076A (en) 2010-08-30
EP1648441A1 (en) 2006-04-26
UA82539C2 (en) 2008-04-25
US20050037062A1 (en) 2005-02-17
OA13190A (en) 2006-12-13
BRPI0412239A (pt) 2006-09-12
HRP20060021A2 (en) 2006-02-28
GT200400134A (es) 2005-02-22
TW200522946A (en) 2005-07-16
TNSN06012A1 (en) 2007-10-03

Similar Documents

Publication Publication Date Title
HN2003000408A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos.
NI200900076A (es) Nuevos derivados de 1,4-benzotiepina-1,1-dióxido sustituidos con radicales bencilo, método para su preparación, productos farmacéuticos que comprenden estos compuestos y su uso.
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
SV2008002828A (es) Agentes para prevenir y tratar trastornos que involucran la modulacion de los receptores ryr ref. 19240-619-sv1
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
NI200900031A (es) Compuestos de n-metilaminometil isoindol y composiciones que los comprenden y métodos para usar los mismos.
PA8592201A1 (es) Nuevos derivados de fluoroglicosidos aromaticos, medicamentos que contienen estos compuestos y sus usos
CR10479A (es) Modulares bencimidazolicos de vr1
AR062211A1 (es) Derivados de 6-carboxi-normorfinano. composiciones farmaceuticas
BRPI0418330A (pt) composições sólidas de drogas de solubilidade baixa e poloxámeros
HN2003000183A (es) Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
UY27852A1 (es) Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
CR8178A (es) Sistemas de emulsion que contienen derivados de azetidina
SV1999000115A (es) Derivados de sulfonamida ref. x-12301
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
ECSP066292A (es) Sistemas semi-sólidos que contienen derivados de azetidina
ECSP045108A (es) Formulación sólida para utilizar como medicamento a base de un derivado de piperazinurea
HN2002000082A (es) Composiciones que contienen imidazotriazinona para administracion nasal
UY27824A1 (es) Nueva formulación para la administración parenteral de crobenetina.
GT200500084A (es) D-homo-17-cloro-16 (17) eno esteroides.
HN2002000084A (es) Fenil - heterociclil - eteres
HN2002000049A (es) Nuevos compuestos antiinflamatorios de triazolopiridinas
UY27823A1 (es) Nueva formulación para la administración parenteral de un bloqueante del canal del na
CL2004002134A1 (es) Compuestos derivados de hidroxietilamina sustituidas, inhibidores de beta secretasa; y su uso para preparar un medicamento para tratar alzheimer, demencias degenerativas, demencia de origen vascular y degenerativos mezclado, entre otras.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)